Trading update

MKTUPDTE

Tue, Jan 25 2022 08:30 am

25 January 2022

Green Cross Health (NZX:GXH) is currently experiencing higher than anticipated revenue and profitability relative to the prior period. For the 9 months to 31 December 2021, the company has experienced an increase in revenue of approximately 14%.

Group CEO Rachael Newfield said “This uplift is primarily the result of increased COVID-19 related activity across the company’s three divisions of Medical, Pharmacy and Community Health as well as the impact of recent acquisitions in the Medical division. The company notes that this uplift may not continue in full into the next financial year due to the uncertain and changeable outlook for COVID-19 vaccination and swabbing activity”.

Whilst Omicron has introduced further uncertainty, Net Profit After Tax Attributable to Shareholders for the 12 months to 31 March 2022 is projected to exceed the prior period result by $4.5m - $6.5m*. Green Cross Health is scheduled to release its audited full year result for the year to 31 March 2022 on 27 May 2022.

* $5.5m - $7.5m excluding one-off and extraordinary amounts.

ENDS

Contact:
Ben Doshi
[email protected]

Rachael Newfield
[email protected]

About Green Cross Health
Green Cross Health (NZX: GXH) is a trusted New Zealand primary healthcare provider with multidisciplinary healthcare teams with the purpose of working together to support healthier communities. New Zealand owned and operated, Green Cross Health operates under branded groups Unichem and Life Pharmacies, The Doctors medical centres, Total Care Health community nursing services and Access Community Health to provide support, care and advice to diverse New Zealand communities.